Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 7/18/2025

Management of Hypoglycemia in Patients Treated with Insulin NPH

Introduction to Hypoglycemia Management

  • The American Diabetes Association recommends immediate administration of 10-20 g of dextrose (glucose solution 10%) intravenously when blood glucose levels are <70 mg/dL in patients treated with insulin NPH to prevent severe complications 1
  • Patients with a history of severe hypoglycemia require more frequent monitoring due to the high risk of mortality associated with even mild hypoglycemia 2

Diagnosis and Intervention

  • Mild to moderate hypoglycemia (55-69 mg/dL) requires immediate intervention due to the increased risk of mortality associated with even mild hypoglycemia 1
  • Severe hypoglycemia (<55 mg/dL) requires urgent intervention due to the high risk of neurological deterioration and mortality 1
  • Neurological patients should consider a higher threshold (<100 mg/dL) for intervention 1

Treatment Protocol

  • Immediately stop the infusion of insulin NPH when blood glucose levels are <70 mg/dL 1
  • Administer 10-20 g of dextrose (glucose solution 10%) intravenously 1
  • Titrate the dose according to the initial hypoglycemia value to avoid overcorrection 1
  • Repeat blood glucose measurement in 15 minutes and administer additional doses as needed 1, 2
  • Goal: Achieve blood glucose levels >70 mg/dL, avoiding iatrogenic hyperglycemia 1

Monitoring and Prevention

  • Continue monitoring blood glucose levels every 15 minutes until stabilization >70 mg/dL 1
  • Once stabilized, perform checks every 1-2 hours to detect possible relapses 1
  • Consider adjusting the dose of NPH to prevent future episodes 3

Patient Education and Prevention

  • Evaluate the need to reduce the dose of NPH (especially if there are recurrent episodes) 3
  • Consider switching to basal insulin analogs (such as insulin glargine) that have a lower risk of hypoglycemia than NPH 3
  • Educate the patient on early recognition of hypoglycemia symptoms
  • Ensure regular meal schedules that coincide with the peak action of NPH 3